Reckitt Benckiser Group (RB) – Investment Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Reckitt Benckiser Group (LON: RB):

  • 9/4/2019 – Reckitt Benckiser Group had its “buy” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 9/3/2019 – Reckitt Benckiser Group had its “overweight” rating reaffirmed by analysts at Barclays PLC.
  • 9/2/2019 – Reckitt Benckiser Group had its “neutral” rating reaffirmed by analysts at Goldman Sachs Group Inc. They now have a GBX 7,100 ($92.77) price target on the stock, down previously from GBX 7,200 ($94.08).
  • 9/2/2019 – Reckitt Benckiser Group was given a new GBX 7,700 ($100.61) price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 8/29/2019 – Reckitt Benckiser Group had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 8/19/2019 – Reckitt Benckiser Group had its “neutral” rating reaffirmed by analysts at UBS Group AG. They now have a GBX 6,500 ($84.93) price target on the stock.
  • 8/7/2019 – Reckitt Benckiser Group had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 8/5/2019 – Reckitt Benckiser Group had its “underperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a GBX 5,900 ($77.09) price target on the stock.
  • 8/1/2019 – Reckitt Benckiser Group was given a new GBX 5,700 ($74.48) price target on by analysts at Societe Generale. They now have a “sell” rating on the stock.
  • 7/31/2019 – Reckitt Benckiser Group was given a new GBX 5,800 ($75.79) price target on by analysts at Credit Suisse Group AG. They now have a “sell” rating on the stock.
  • 7/31/2019 – Reckitt Benckiser Group was given a new GBX 7,700 ($100.61) price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 7/30/2019 – Reckitt Benckiser Group had its “under review” rating reaffirmed by analysts at Shore Capital.
  • 7/30/2019 – Reckitt Benckiser Group was given a new GBX 5,900 ($77.09) price target on by analysts at Royal Bank of Canada. They now have a “sell” rating on the stock.
  • 7/30/2019 – Reckitt Benckiser Group was given a new GBX 7,200 ($94.08) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 7/30/2019 – Reckitt Benckiser Group had its “neutral” rating reaffirmed by analysts at Bryan, Garnier & Co. They now have a GBX 6,870 ($89.77) price target on the stock, up previously from GBX 6,800 ($88.85).
  • 7/30/2019 – Reckitt Benckiser Group was given a new GBX 8,100 ($105.84) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 7/30/2019 – Reckitt Benckiser Group was given a new GBX 9,000 ($117.60) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 7/30/2019 – Reckitt Benckiser Group had its “buy” rating reaffirmed by analysts at Liberum Capital.
  • 7/30/2019 – Reckitt Benckiser Group had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 8,000 ($104.53) price target on the stock.
  • 7/29/2019 – Reckitt Benckiser Group had its “neutral” rating reaffirmed by analysts at UBS Group AG. They now have a GBX 6,600 ($86.24) price target on the stock.
  • 7/18/2019 – Reckitt Benckiser Group was given a new GBX 7,900 ($103.23) price target on by analysts at HSBC Holdings plc. They now have a “buy” rating on the stock.
  • 7/16/2019 – Reckitt Benckiser Group had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 7/15/2019 – Reckitt Benckiser Group was given a new GBX 5,900 ($77.09) price target on by analysts at Royal Bank of Canada. They now have a “sell” rating on the stock.
  • 7/15/2019 – Reckitt Benckiser Group had its “overweight” rating reaffirmed by analysts at Morgan Stanley.
  • 7/12/2019 – Reckitt Benckiser Group had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 8,000 ($104.53) price target on the stock.
  • 7/11/2019 – Reckitt Benckiser Group was given a new GBX 7,200 ($94.08) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 7/11/2019 – Reckitt Benckiser Group was given a new GBX 9,000 ($117.60) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 7/11/2019 – Reckitt Benckiser Group had its “buy” rating reaffirmed by analysts at Liberum Capital.
  • 7/9/2019 – Reckitt Benckiser Group had its price target raised by analysts at Barclays PLC from GBX 7,500 ($98.00) to GBX 8,100 ($105.84). They now have an “overweight” rating on the stock.
  • 7/8/2019 – Reckitt Benckiser Group was given a new GBX 5,800 ($75.79) price target on by analysts at Credit Suisse Group AG. They now have a “sell” rating on the stock.
  • 7/8/2019 – Reckitt Benckiser Group was given a new GBX 5,300 ($69.25) price target on by analysts at Royal Bank of Canada. They now have a “sell” rating on the stock.

The stock has a market capitalization of $46.08 billion and a price-to-earnings ratio of 32.63. The company has a current ratio of 0.59, a quick ratio of 0.43 and a debt-to-equity ratio of 85.08. Reckitt Benckiser Group Plc has a 12-month low of GBX 5,559 ($72.64) and a 12-month high of GBX 7,174 ($93.74). The firm has a 50-day moving average price of GBX 6,288.26 and a 200 day moving average price of GBX 6,245.94.

The firm also recently declared a dividend, which will be paid on Thursday, September 26th. Shareholders of record on Thursday, August 22nd will be paid a GBX 73 ($0.95) dividend. The ex-dividend date of this dividend is Thursday, August 22nd. This represents a dividend yield of 1.13%. Reckitt Benckiser Group’s dividend payout ratio (DPR) is 0.73%.



In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah sold 81,063 shares of the business’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of GBX 6,399 ($83.61), for a total value of £5,187,221.37 ($6,778,023.48).

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: What is a Lock-Up Period?

Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.